维普期刊资源整合服务平台（V6.5）

59篇 您的检索式：期刊名="Mol CancerTher"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Small-molecule inhibitor of theAP endonuclease 1/REF-l E3330 inhibits pancreaticcancer cell growth and migration 显示文摘	Zou GM Maitra A	2008	Mol CancerTher2008，7，7：	1
2	Rapamycin and UCN- 01synergistically induce apoptosis in human leukemia cellsthrough a process that is regulated by the Raf- 1/MEK/ERK,Akt, and JNK signal transduction pathways 显示文摘	Hahn M Li W Yu C	2005	Mol CancerTher2005，4，3：	1
3	Bim-targeted cancer therapy: a link between drug action and underlying molecular changes显示文摘	Akiyama T Dass CR Choong PF	2009	Mol CancerTher2009，8，12：	1
4	Tumor chemosensitizationstrategies based on apoptosis manipulations显示文摘	Shabbits JA Hu HP Mayer LD	2003	Mol CancerTher2003，2，8：	1
5	Aurora kinases' inhibitors-rising stars in cancer therapeutics显示文摘	DarAA GoffLW Majid S	2010	Mol CancerTher2010，9，2：	1
6	HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2显示文摘	Ikezoe T Saito T Bandobashi K	2004	Mol CancerTher2004，3，4：	1
7	ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity显示文摘	Munshi N Jeay S Li Y	2010	Mol CancerTher2010，9，6：	1
8	Artemin-stimulated pro- gression of human non-small cell lung carcinoma is media- ted by BCL2显示文摘	Tang JZ Kong XJ Kang J	2010	Mol CancerTher2010，9，6：	1
9	Triptolide inhibits thegrowth and metastasis of solid tumors 显示文摘	Yang S Chen J Guo Z	2003	Mol CancerTher2003，2，1：	1
10	PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer显示文摘	Gonzahz-AnguloAM Ferrer-LozanoJ Stemke-HahK	2011	Mol CancerTher2011，10，6：	1
11	Characterisa- tion of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin显示文摘	Newbold A Lindemann RK Cluse LA	2008	Mol CancerTher2008，7，5：	1
12	ClassⅢbeta-tubulin expression in tumor cells p redicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel显示文摘	Seve P Mackey J Isaac S	2005	Mol CancerTher2005，4，12：	1
13	Class 显示文摘	Sve P Mackey J Isaac S	2005	Mol CancerTher2005，4，12：	1
14	AT7867 is a potentand oral inhibitor of AKT and p7O $6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth显示文摘	Grimshaw K M Hunter L J Yap T A	2010	Mol CancerTher2010，9，5：	1
15	Omega-3 polyunsaturated fattyacids inhibit hepatocellular carcinoma cell growth throughblocking beta-catenin and cyclooxygenase-2显示文摘	LIM K HAN C DAI Y	2009	Mol CancerTher2009，8，11：	1
16	Hematopoietic expression of0 (6) -methylguanine DNA methyltransferase-Pl 40K allows intensivetreatment of human glioma xenografts with combination 0 (6) -benzyl-guanineand 1,3-bis-(2-chloroethyl) -1 -nit rosourea 显示文摘	Kreklau EL Pollok KE Bailey BJ	2003	Mol CancerTher2003，2，12：	1
17	PP2A inhibition is acommon event in colorectal cancer and its restoration usingFTY720 shows promising therapeutic potential 显示文摘	Cristobal I Manso R Rincon R	2014	Mol CancerTher2014，13，4：	1
18	Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity显示文摘	I Ding WQ Lind SE	2007	Mol CancerTher2007，6，4：	1
19	Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation 显示文摘	Deeb D Jiang H Gao X Hafner MS	2004	Mol CancerTher2004，3，7：	1
20	Dual inhibition of tumor en- ergy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models 显示文摘	Cheong JH Park ES Liang J	2011	Mol CancerTher2011，10，12：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示